GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theriva Biologics Inc (FRA:SFY) » Definitions » Price-to-Tangible-Book

Theriva Biologics (FRA:SFY) Price-to-Tangible-Book : 0.91 (As of May. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Theriva Biologics Price-to-Tangible-Book?

As of today (2024-05-14), Theriva Biologics's share price is €0.318. Theriva Biologics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €0.35. Hence, Theriva Biologics's Price to Tangible Book Ratio of today is 0.91.

The historical rank and industry rank for Theriva Biologics's Price-to-Tangible-Book or its related term are showing as below:

FRA:SFY' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.25   Med: 1.24   Max: 71.62
Current: 0.99

During the past 13 years, Theriva Biologics's highest Price to Tangible Book Ratio was 71.62. The lowest was 0.25. And the median was 1.24.

FRA:SFY's Price-to-Tangible-Book is ranked better than
93.11% of 1220 companies
in the Biotechnology industry
Industry Median: 2.71 vs FRA:SFY: 0.99

A closely related ratio is called PB Ratio. As of today, Theriva Biologics's share price is €0.318. Theriva Biologics's Book Value per Sharefor the quarter that ended in Mar. 2024 was €1.68. Hence, Theriva Biologics's P/B Ratio of today is 0.19.


Theriva Biologics Price-to-Tangible-Book Historical Data

The historical data trend for Theriva Biologics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theriva Biologics Price-to-Tangible-Book Chart

Theriva Biologics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.51 0.24 0.62

Theriva Biologics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.77 0.49 0.62 1.16

Competitive Comparison of Theriva Biologics's Price-to-Tangible-Book

For the Biotechnology subindustry, Theriva Biologics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theriva Biologics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theriva Biologics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Theriva Biologics's Price-to-Tangible-Book falls into.



Theriva Biologics Price-to-Tangible-Book Calculation

Theriva Biologics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=0.318/0.349
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Theriva Biologics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Theriva Biologics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Theriva Biologics (FRA:SFY) Business Description

Traded in Other Exchanges
Address
9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11, leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Theriva Biologics (FRA:SFY) Headlines

From GuruFocus

SOFI WEALTH, LLC Goes on Buying Spree in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-25-2022